Abstract:Objective To investigate the safety and feasibility of hysteroscopic uterus myoma electromyoma in daytime operation ward. Methods From April 2016 to October 2017, 87 patients with uterus submucous myoma (44 cases of type O, 24 cases of type Ⅰ, 19 cases of type Ⅱ) admitted to the First Affiliated Hospital of Xinjiang Medical University according to day surgery standard were selected as the study group. In the same period, 112 patients with uterus submucous myoma (55 cases of type O, 32 cases of type Ⅰ, 25 cases of type Ⅱ) according to day surgery standard were selected as control group. The operation was completed by the same doctor and his team. Patients were followed up for 6 months. Preoperative per capita preoperation bed days, intraoperative conditions, hospitalization expenses, laboratory fees, cost of Western medicine, postoperative complications, per capita hospitalization time, readmission rate, satisfaction rate were compared between two groups. Results There were no significant differences in operation time, intraoperative bleeding and satisfaction rate between two groups (P > 0.05). No complications and no plan of enterance to the hospital occurred in two groups after operation. Preoperative preoperation bed days, per capita hospitalization time in the study group were shorter than control group (P < 0.05). The laboratory fees, cost of Western medicine per capita hospitalization expenses in study group were lower than control group (P < 0.05). Conclusion Under the premise of strict admittance standards, hysteroscopic uterus myoma electromyoma in daytime operation ward is safe, efficient, convenient, and can reduce hospitalization time and hospitalization cost significantly.